Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Schnell O, Battelino T, Bergenstal R, Birkenfeld AL, Ceriello A, Cheng A, Davies M, Edelman S, Forst T, Giorgino F, Green J, Groop PH, Hadjadj S, J L Heerspink H, Hompesch M, Izthak B, Ji L, Kanumilli N, Mankovsky B, Mathieu C, Miszon M, Mustafa R, Nauck M, Pecoits-Filho R, Pettus J, Ranta K, Rodbard HW, Rossing P, Ryden L, Schumm-Draeger PM, Solomon SD, Škrha J, Topsever P, Vilsbøll T, Wilding J, Standl E. Schnell O, et al. Among authors: vilsboll t. Cardiovasc Diabetol. 2023 Mar 16;22(1):59. doi: 10.1186/s12933-023-01788-6. Cardiovasc Diabetol. 2023. PMID: 36927451 Free PMC article.
Incretin-based therapies: viewpoints on the way to consensus.
Nauck MA, Vilsbøll T, Gallwitz B, Garber A, Madsbad S. Nauck MA, et al. Among authors: vilsboll t. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S223-31. doi: 10.2337/dc09-S315. Diabetes Care. 2009. PMID: 19875556 Free PMC article. Review. No abstract available.
The effect of glucagon-like peptide 1 on cardiovascular risk.
Sivertsen J, Rosenmeier J, Holst JJ, Vilsbøll T. Sivertsen J, et al. Among authors: vilsboll t. Nat Rev Cardiol. 2012 Jan 31;9(4):209-22. doi: 10.1038/nrcardio.2011.211. Nat Rev Cardiol. 2012. PMID: 22290234 Review.
Glucagon and type 2 diabetes: the return of the alpha cell.
Lund A, Bagger JI, Christensen M, Knop FK, Vilsbøll T. Lund A, et al. Among authors: vilsboll t. Curr Diab Rep. 2014 Dec;14(12):555. doi: 10.1007/s11892-014-0555-4. Curr Diab Rep. 2014. PMID: 25344790 Review.
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics.
Jørgensen PG, Jensen MT, Mogelvang R, von Scholten BJ, Bech J, Fritz-Hansen T, Galatius S, Biering-Sørensen T, Andersen HU, Vilsbøll T, Rossing P, Jensen JS. Jørgensen PG, et al. Among authors: vilsboll t. Diab Vasc Dis Res. 2016 Sep;13(5):321-30. doi: 10.1177/1479164116645583. Epub 2016 May 21. Diab Vasc Dis Res. 2016. PMID: 27208801 Free article.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. Among authors: vilsboll t. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
429 results